DOI QR코드

DOI QR Code

Evaluating the Association between Anemia and the Severity of Liver Disease in Children with Cirrhosis: A Cross-Sectional Study from 2015 to 2020

  • Seyed Mohsen Dehghani (Shiraz Transplant Research Center, Shiraz University of Medical Science) ;
  • Iraj Shahramian (Department of Pediatrics, School of Medicine, Namazi Teaching Hospital, Abu Ali Sina for Medicine & Organ Transplant, Shiraz University of Medical Sciences) ;
  • Hamideh Salehi (Shiraz Transplant Research Center, Shiraz University of Medical Science) ;
  • Leila Kasraian (Blood Transfusion Research Centre, Higher Institute for Research and Education in Transfusion Medicine) ;
  • Maryam Ataollahi (Shiraz Transplant Research Center, Shiraz University of Medical Science) ;
  • Masoud Tahani (Pediatric Gastroenterology and Hepatology Research Center, Zabol University of Medical Sciences)
  • Received : 2023.04.14
  • Accepted : 2024.05.29
  • Published : 2024.09.15

Abstract

Purpose: Liver cirrhosis is a major cause of hospital admission and mortality among children. Understanding the factors that influence disease severity is essential for preventing and reducing mortality. This study explored the association between hemoglobin levels and liver disease severity in children with cirrhosis. Methods: This cross-sectional study included 326 children with cirrhosis admitted to Namazi Teaching Hospital between 2015 and 2020. Clinical data, Child-Turcotte-Pugh (CTP) scores, and pediatric end-stage liver disease/model for end-stage liver disease (PELD/MELD) scores were collected to assess disease severity. Anemia was defined based on age, sex, and hemoglobin levels. Results: Among the children with cirrhosis, 275 (84.4%) were anemic, with a mean age of 5.4±4.8 years. The overall mean hemoglobin level was 9.2±2.1 g/dL. A significant inverse correlation was observed between hemoglobin levels and CTP and PELD/MELD scores in children with anemia (p<0.001). Moreover, lower hemoglobin levels were associated with more higher CTP classes (p<0.001). Conclusion: According to the data analysis, a significant correlation was observed between hemoglobin level and the severity of liver disease, and hemoglobin level decreased with increasing severity of liver disease. According to CTP class, the mean hemoglobin level decreased progressively as the disease progressed. A comparison of the mean CTP scores between children with and those without anemia revealed that those with anemia had more severe disease than those without anemia.

Keywords

Acknowledgement

This study is based on a dissertation supported by the Shiraz University of Medical Sciences.

References

  1. Pinzani M, Rosselli M, Zuckermann M. Liver cirrhosis. Best Pract Res Clin Gastroenterol 2011;25:281-90. https://doi.org/10.1016/j.bpg.2011.02.009
  2. Dehghani SM, Imanieh MH, Haghighat M, Malekpour A, Falizkar Z. Etiology and complications of liver cirrhosis in children:report of a single center from southern Iran. Middle East J Dig Dis 2013;5:41-6.
  3. Scheiner B, Semmler G, Maurer F, Schwabl P, Bucsics TA, Paternostro R, et al. Prevalence of and risk factors for anaemia in patients with advanced chronic liver disease. Liver Int 2020;40:194-204. https://doi.org/10.1111/liv.14229
  4. Zareifar S, Dehghani SM, Rahanjam N, Farahmand Far MR. Prevalence of Iron deficiency anemia in children with liver cirrhosis: a cross-sectional study. Int J Hematol Oncol Stem Cell Res 2015;9:128-32.
  5. Gonzalez-Casas R, Jones EA, Moreno-Otero R. Spectrum of anemia associated with chronic liver disease. World J Gastroenterol 2009;15:4653-8. https://doi.org/10.3748/wjg.15.4653
  6. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973;60:646-9. https://doi.org/10.1002/bjs.1800600817
  7. Infante-Rivard C, Esnaola S, Villeneuve JP. Clinical and statistical validity of conventional prognostic factors in predicting short-term survival among cirrhotics. Hepatology 1987;7:660-4. https://doi.org/10.1002/hep.1840070408
  8. Wiesner RH. Evidence-based evolution of the MELD/PELD liver allocation policy. Liver Transpl 2005;11:261-3. https://doi.org/10.1002/lt.20362
  9. Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003;124:91-6. https://doi.org/10.1053/gast.2003.50016
  10. Singh S, Manrai M, V S P, Kumar D, Srivastava S, Pathak B. Association of liver cirrhosis severity with anemia: does it matter? Ann Gastroenterol 2020;33:272-6. https://doi.org/10.20524/aog.2020.0478
  11. Romano F, Stroppa P, Bravi M, Casotti V, Lucianetti A, Guizzetti M, et al. Favorable outcome of primary liver transplantation in children with cirrhosis and hepatocellular carcinoma. Pediatr Transplant 2011;15:573-9. https://doi.org/10.1111/j.1399-3046.2011.01528.x
  12. Keller PD, Nute WL Jr. Cirrhosis of the liver in children: a clinical and pathologic study of 40 cases. J Pediatr 1949;34:588-615. https://doi.org/10.1016/S0022-3476(49)80285-X
  13. Kliegman R, Nelson WE, Behrman RE, Jenson HB. Nelson textbook of pediatrics e-book. 18th ed. Philadelphia: Sounders, 2007.
  14. Alamneh YM, Akalu TY, Shiferaw AA, Atnaf A. Magnitude of anemia and associated factors among children aged 6-59 months at Debre Markos referral hospital, Northwest Ethiopia: a hospital-based cross sectional study. Ital J Pediatr 2021;47:172.
  15. Jain D, Aggarwal HK, Rao A, Dahiya S, Singla S. Hematological spectrum in patients with alcoholic liver cirrhosis: a model of end-stage liver disease score based approach. Int J Adv Med 2016;3:234-40. https://doi.org/10.18203/2349-3933.ijam20160494
  16. Kliegman R, Stanton B, St Geme JW, Schor NF, Behrman RE, Nelson WE. Nelson textbook of pediatrics. 21st ed. Philadelphia: Elsevier, 2020.
  17. Trefts E, Gannon M, Wasserman DH. The liver. Curr Biol 2017;27:R1147-51. https://doi.org/10.1016/j.cub.2017.09.019
  18. Knell AJ. Liver function and failure: the evolution of liver physiology. J R Coll Physicians Lond 1980;14:205-8.
  19. Barshes NR, Lee TC, Udell IW, O'mahoney CA, Karpen SJ, Carter BA, et al. The pediatric end-stage liver disease (PELD) model as a predictor of survival benefit and posttransplant survival in pediatric liver transplant recipients. Liver Transpl 2006;12:475-80. https://doi.org/10.1002/lt.20703
  20. Pinto RB, Schneider AC, da Silveira TR. Cirrhosis in children and adolescents: an overview. World J Hepatol 2015;7:392-405. https://doi.org/10.4254/wjh.v7.i3.392